Precision Infrastructure
Advanced Manufacturing & Scientific Discovery
Pioneering next-generation oncology therapeutics through a vertically integrated ecosystem of WHO-GMP certified facilities and rigorous research protocols.
Manufacturing Excellence
Automated Sterile Formulation
Our state-of-the-art facility utilizes closed-loop robotic systems for the production of lyophilized injectables, ensuring zero-contamination environments for oncology treatments.
Batch Reliability
"Precision at scale is the foundation of patient safety."
Air Quality Control
Class 100 HEPA filtration systems maintaining ISO 5 standards across all critical processing zones.
API Synthesis
In-house synthesis of high-potency active pharmaceutical ingredients to ensure supply chain resilience.
Cold Chain Logistics
IoT-monitored -80°C storage capabilities ensuring biological integrity from lab to patient.
Rigorous Quality Assurance
Our QA framework exceeds international regulatory standards, employing a three-tier validation process for every molecule produced.
- Real-time Analytical MonitoringHPLC and Mass Spectrometry during synthesis.
- LIMS IntegrationFully digital Laboratory Information Management Systems.
Current Research Priorities
T-Cell Engineering
Advancing chimeric antigen receptor (CAR) T-cell therapies for refractory hematologic malignancies.
Precision Biomarkers
Developing companion diagnostics to predict patient response to targeted biological agents.
Nano-drug Carriers
Optimizing lipid nanoparticle delivery systems for enhanced penetration into solid tumor tissues.
Global Expansion Roadmap
Strategically scaling our footprint to ensure high-efficacy oncology care is accessible across emerging and established markets.
2027-2028
Sri Lanka
South Asia
2027-2028
Singapore
Southeast Asia
2029-2030
United Arab Emirates
Middle East
2031
Europe
European Network